Aflibercept OverviewAflibercept, sold under the brandname Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It was developed by Regeneron Pharmaceuticals and is approved in the United States and Europe. It is an inhibitor of vascular endothelial growth factor (VEGF). Contents 1 Medical use 2 Contraindications 3 Adverse effects 4 Interactions 5 Mechanism of action 6 Composition 7...
Read more Aflibercept Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Aflibercept
Recent Aflibercept Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 40mg/ml